I think any presentations will be peripheral and will have no positive impact on the stock price. Will be another rug pull and then back to the good old quiet period.
A journal publication is a bigger deal that ASCO in my view... and I'm guessing that will follow ASCO in short order. After that, MAA filing. We've got catalysts.